Key result
Clerodendrum volubile extract mitigates doxorubicin-induced liver and kidney injury in rats.
Why the study?
Hepatorenal toxicity is a side effect of doxorubicin used in cancer treatment, and the potential protective effect of Clerodendrum volubile ethanol leaf extract was investigated.
Does Clerodendrum volubile ethanol leaf extract prevent doxorubicin-induced hepatorenal toxicities in male Wistar rats?
Population
Male Wistar rats
Comparison
Pretreatment with Clerodendrum volubile ethanol leaf extract vs doxorubicin-treated rats without extract pretreatment
Design
Preclinical experimental study
Follow-up
14 days
Authors
Loading...
May protect against doxorubicin hepatorenal injury in rats; hypothesis-generating and should not change clinical practice.
Does Clerodendrum volubile ethanol leaf extract prevent doxorubicin-induced hepatorenal toxicities in male Wistar rats?
Clerodendrum volubile ethanol leaf extract demonstrates protective effects against doxorubicin-induced hepatorenal toxicity in a rat model, likely mediated through suppression of oxidative stress.
Adeneye et al. (2021) studied Doxorubicin-induced hepatorenal toxicities. Clerodendrum volubile ethanol leaf extract (CVE) vs. DOX-treated rats was evaluated on Hepatorenal toxicity (serum ALT, AST, ALP, Cr, BUN, CAT, SOD, GPx, MDA). Oral pretreatment with Clerodendrum volubile ethanol leaf extract (50-400 mg/kg/day) ameliorated doxorubicin-induced liver and kidney injury in rats by lowering serum ALT, AST, ALP, Cr, and BUN levels.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: